Perspective Therapeutics (CATX) Return on Capital Employed Growth (1y) (2012 - 2026)
Perspective Therapeutics (CATX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 216.00 |
| 10 | Perspective Therapeutics | 384.27 Mn | 384.27 Mn | - | 228.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89,766.00 |
| Mar 31, 2026 | 105,713.00 |
| Dec 31, 2025 | 127,935.00 |
| Sep 30, 2025 | -2,329.00 |
| Jun 30, 2025 | -1,915.00 |
| Mar 31, 2025 | -546.00 |
| Dec 31, 2024 | 2,012.00 |
| Sep 30, 2024 | 1,656.00 |
| Jun 30, 2024 | 1,332.00 |
| Mar 31, 2024 | 554.00 |
| Dec 31, 2023 | -1,447.00 |
| Sep 30, 2023 | -870.00 |
| Jun 30, 2023 | -1,455.00 |
| Mar 31, 2023 | -2,491.00 |
| Dec 31, 2022 | -2,673.00 |
| Sep 30, 2022 | -2,005.00 |
| Jun 30, 2022 | -1,246.00 |
| Mar 31, 2022 | 245.00 |
| Dec 31, 2021 | 2,682.00 |
| Sep 30, 2021 | 4,525.00 |